Recently , there's rising attention on the medicinal sector in the nation . While global giants historically held significant influence, a change appears to be happening . Several domestic entities have seen considerable progress, disrupting the incumbent order . Queries are now being raised about whether this represents a genuine transition toward

India's pharmaceutical sector, renowned for its budget-friendly medications and broad manufacturing capabilities, faces a growing concern: monopolies. While generic drug production has been a cornerstone of India's success, certain companies have emerged with dominant market shares, potentially impeding access to essential drugs and driving up pric